value & access

Views & Analysis

Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono, on the evolution of the Value & Access function.

Patients

A phase 1/2 trial in AL amyloidosis saw 100% of patients obtaining at least a very good partial response with 90% obtaining a complete response.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

value &amp; access